Hemodynamic monitoring ensures precision and is used for remotely controlled and minimally invasive procedures. The current systems comprise of computer-controlled electromechanical devices that work in response to the controls manipulated by surgeons. Hemodynamic monitoring involves performing operative procedures with the assistance of robotic technology. The global hemodynamic monitoring market is expected to register a CAGR of 5.5% during the forecast period 2018 to 2023.

Highlights

The global Hemodynamic Monitoring market was valued at US$ 716.1 million in 2022 and is anticipated to reach US$ 816 million by 2029, witnessing a CAGR of 2.2% during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

Increasing demand for hemodynamic monitoring in disease treatment and critical care is one of the key factors driving the growth of this market globally. In infants, structural defects during the development of the heart in the fetal stage lead to congenital heart diseases. It is estimated that about 40,000 infants in the US are born with this disease every year, which is lethal in most cases while many such cases remain undetected. Physicians use pulse oximetry to detect this disease in infants which involve the measurement of oxygen levels in the blood. Low oxygen levels in the blood of infants signify the presence of heart problems. Additionally, in women, rheumatic heart disease can cause hemodynamic changes that can lead to severe complications in pregnancy, labor, delivery, and postpartum recovery. Therefore, physicians perform hemodynamic monitoring using pulmonary artery catheter that helps administer and maintain adequate perfusion pressure. This helps to identify these risk factors and improve clinical status. The increasing need for hemodynamic monitoring in cardiovascular surgeries will bolster this market’s growth prospects until the end of 2023.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Hemodynamic Monitoring, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hemodynamic Monitoring.

The Hemodynamic Monitoring market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Hemodynamic Monitoring market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Hemodynamic Monitoring companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.


By Company


Edwards Lifesciences

PULSION Medical Systems

LiDCO

ICU Medical

Cheetah Medical

Deltex Medical Group

FUJIFILM SonoSite

GE Healthcare

Mindray

Nihon Kohden

NImedical

Osypka Medical

Tensys Medical

Uscom


Segment by Type


Hemodynamic Monitoring Consumables

Hemodynamic Monitoring System


Segment by Application


Minimally Invasive

Invasive

Non-Invasive

By Region

North America

United States

Canada

Europe

Germany

France

UK

Italy

Russia

Nordic Countries

Rest of Europe

Asia-Pacific

China

Japan

South Korea

Southeast Asia

India

Australia

Rest of Asia

Latin America

Mexico

Brazil

Rest of Latin America

Middle East & Africa

Turkey

Saudi Arabia

UAE

Rest of MEA

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Hemodynamic Monitoring companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.

Chapter 12: The main points and conclusions of the report.